6-[5-[4-amino-6-(2-piperazin-1-ylethylamino)-1,3,5-triazin-2-yl]-2-bicyclo[2.2.1]heptanyl]-1,3,5-triazine-2,4-diamine

C19H30N12 — CID 54561983

IUPAC6-[5-[4-amino-6-(2-piperazin-1-ylethylamino)-1,3,5-triazin-2-yl]-2-bicyclo[2.2.1]heptanyl]-1,3,5-triazine-2,4-diamine
SMILESNc1nc(N)nc(C2CC3CC2CC3c2nc(N)nc(NCCN3CCNCC3)n2)n1
InChIInChI=1S/C19H30N12/c20-16-25-14(26-17(21)29-16)12-8-11-7-10(12)9-13(11)15-27-18(22)30-19(28-15)24-3-6-31-4-1-23-2-5-31/h10-13,23H,1-9H2,(H4,20,21,25,26,29)(H3,22,24,27,28,30)
InChIKeyZREVSIVZLVDBDI-UHFFFAOYSA-N
MW426.53 g/mol
LogP-0.58
Rot. Bonds6

About 6-[5-[4-amino-6-(2-piperazin-1-ylethylamino)-1,3,5-triazin-2-yl]-2-bicyclo[2.2.1]heptanyl]-1,3,5-triazine-2,4-diamine

6-[5-[4-amino-6-(2-piperazin-1-ylethylamino)-1,3,5-triazin-2-yl]-2-bicyclo[2.2.1]heptanyl]-1,3,5-triazine-2,4-diamine (PubChem CID 54561983) has the molecular formula C19H30N12 and a molecular weight of 426.53 g/mol. Its IUPAC name is 6-[5-[4-amino-6-(2-piperazin-1-ylethylamino)-1,3,5-triazin-2-yl]-2-bicyclo[2.2.1]heptanyl]-1,3,5-triazine-2,4-diamine.

Molecular Properties

Compound Name6-[5-[4-amino-6-(2-piperazin-1-ylethylamino)-1,3,5-triazin-2-yl]-2-bicyclo[2.2.1]heptanyl]-1,3,5-triazine-2,4-diamine
PubChem CID54561983
Molecular FormulaC19H30N12
Molecular Weight426.53 g/mol
Exact Mass426.27
IUPAC Name6-[5-[4-amino-6-(2-piperazin-1-ylethylamino)-1,3,5-triazin-2-yl]-2-bicyclo[2.2.1]heptanyl]-1,3,5-triazine-2,4-diamine
SMILESNc1nc(N)nc(C2CC3CC2CC3c2nc(N)nc(NCCN3CCNCC3)n2)n1
InChIInChI=1S/C19H30N12/c20-16-25-14(26-17(21)29-16)12-8-11-7-10(12)9-13(11)15-27-18(22)30-19(28-15)24-3-6-31-4-1-23-2-5-31/h10-13,23H,1-9H2,(H4,20,21,25,26,29)(H3,22,24,27,28,30)
InChIKeyZREVSIVZLVDBDI-UHFFFAOYSA-N
XLogP-0.58
TPSA182.70 Ų
H-Bond Donors5
H-Bond Acceptors12
Rotatable Bonds6
Heavy Atoms31
Complexity—

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500426.53
LogP ≤ 5-0.58
H-Bond Donors ≤ 55
H-Bond Acceptors ≤ 1012

Analyze 6-[5-[4-amino-6-(2-piperazin-1-ylethylamino)-1,3,5-triazin-2-yl]-2-bicyclo[2.2.1]heptanyl]-1,3,5-triazine-2,4-diamine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 6-[5-[4-amino-6-(2-piperazin-1-ylethylamino)-1,3,5-triazin-2-yl]-2-bicyclo[2.2.1]heptanyl]-1,3,5-triazine-2,4-diamine?
The IUPAC name of 6-[5-[4-amino-6-(2-piperazin-1-ylethylamino)-1,3,5-triazin-2-yl]-2-bicyclo[2.2.1]heptanyl]-1,3,5-triazine-2,4-diamine (CID 54561983) is 6-[5-[4-amino-6-(2-piperazin-1-ylethylamino)-1,3,5-triazin-2-yl]-2-bicyclo[2.2.1]heptanyl]-1,3,5-triazine-2,4-diamine.
What is the SMILES notation for 6-[5-[4-amino-6-(2-piperazin-1-ylethylamino)-1,3,5-triazin-2-yl]-2-bicyclo[2.2.1]heptanyl]-1,3,5-triazine-2,4-diamine?
The canonical SMILES for 6-[5-[4-amino-6-(2-piperazin-1-ylethylamino)-1,3,5-triazin-2-yl]-2-bicyclo[2.2.1]heptanyl]-1,3,5-triazine-2,4-diamine is Nc1nc(N)nc(C2CC3CC2CC3c2nc(N)nc(NCCN3CCNCC3)n2)n1.
What is the InChIKey of 6-[5-[4-amino-6-(2-piperazin-1-ylethylamino)-1,3,5-triazin-2-yl]-2-bicyclo[2.2.1]heptanyl]-1,3,5-triazine-2,4-diamine?
The InChIKey is ZREVSIVZLVDBDI-UHFFFAOYSA-N. The full InChI is InChI=1S/C19H30N12/c20-16-25-14(26-17(21)29-16)12-8-11-7-10(12)9-13(11)15-27-18(22)30-19(28-15)24-3-6-31-4-1-23-2-5-31/h10-13,23H,1-9H2,(H4,20,21,25,26,29)(H3,22,24,27,28,30).
What are the key properties of 6-[5-[4-amino-6-(2-piperazin-1-ylethylamino)-1,3,5-triazin-2-yl]-2-bicyclo[2.2.1]heptanyl]-1,3,5-triazine-2,4-diamine?
6-[5-[4-amino-6-(2-piperazin-1-ylethylamino)-1,3,5-triazin-2-yl]-2-bicyclo[2.2.1]heptanyl]-1,3,5-triazine-2,4-diamine has a molecular weight of 426.53 g/mol, XLogP of -0.58, 6 rotatable bonds, 5 hydrogen bond donors, and 12 hydrogen bond acceptors.
Where does this data come from?
All data for 6-[5-[4-amino-6-(2-piperazin-1-ylethylamino)-1,3,5-triazin-2-yl]-2-bicyclo[2.2.1]heptanyl]-1,3,5-triazine-2,4-diamine is sourced from PubChem (CID 54561983), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).